Literature DB >> 20572075

Characterization of human papillomavirus infection in north Taiwan.

Chin-Hung Wang1, Ronald Garingalao Garvilles, Chung-Yung Chen.   

Abstract

The detection of human papillomavirus (HPV) is very important for the evaluation of preventative strategies for cervical cancer. The major objective of this study was to characterize the prevalence of different genotypes of HPV in north Taiwan to contribute to the epidemiological knowledge of HPV infections. Papanicolaou (Pap) cervical smears were collected from 10,543 women aged between 14 and 87 years. The polymerase chain reaction (PCR) and DNA array hybridization techniques were used to genotype 51 different HPV strains. HPV was detected in 1,577 women, which gave an overall HPV prevalence rate of 15%. Forty-eight different genotypes were found in these patients, which included 9.7% that were high-risk HPV (HR-HPV) genotypes. The most common types of HR-HPV in patients, in descending order of frequency, were HPV 52, 16, 58, 56, 39, 51, 18, 68, 31, 33, 59, 45, and 35. HPV 52 was the most frequent type in every age group. The four most common HR-HPV types were found in 56.6% of the patients infected with HR-HPV. In cases that were infected with multiple HPV genotypes, 69.2% had at least one HR-HPV genotype. The rate of infection with HR-HPV was higher in the younger age groups than the older ones. In conclusion, 48 HPV genotypes were identified from a large study of cervical screening samples and the prevalence of HPV genotypes in different age groups was very diverse. The formulation of a public health strategy for HPV vaccination should take into account the prevalence of various HR-HPV/LR-HPV genotypes. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20572075     DOI: 10.1002/jmv.21812

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  HPV Type Distribution and Cervical Cytology among HIV-Positive Tanzanian and South African Women.

Authors:  Joke A M Dols; Gregor Reid; Joelle M Brown; Hugo Tempelman; Tj Romke Bontekoe; Wim G V Quint; Mathilde E Boon
Journal:  ISRN Obstet Gynecol       Date:  2012-06-28

2.  Prevalence of HPV infection among 28,457 Chinese women in Yunnan Province, southwest China.

Authors:  Zheng Li; Feng Liu; Si Cheng; Lei Shi; Zhiling Yan; Jie Yang; Li Shi; Yufeng Yao; Yanbing Ma
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

3.  Prevalence and Genotype Distribution of Human Papillomavirus in Invasive Cervical Cancer, Cervical Intraepithelial Neoplasia, and Asymptomatic Women in Southeast China.

Authors:  Xuelian Wang; Yanli Zeng; Xiumin Huang; Youzhong Zhang
Journal:  Biomed Res Int       Date:  2018-10-08       Impact factor: 3.411

4.  The association between human papillomavirus infection and head and neck cancer: A population-based cohort study.

Authors:  Stella Chin-Shaw Tsai; Jing-Yang Huang; Chuck Lin; Yung-Po Liaw; Frank Cheau-Feng Lin
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

5.  Multi-Infection Patterns and Co-infection Preference of 27 Human Papillomavirus Types Among 137,943 Gynecological Outpatients Across China.

Authors:  Guangdong Liao; Xiyi Jiang; Bin She; Huijuan Tang; Zhongyong Wang; Hongrong Zhou; Yan Ma; Weidong Xu; Hongxing Xu; Wen Chen; Jianguang Ji; Mingrong Xi; Tianhui Chen
Journal:  Front Oncol       Date:  2020-04-07       Impact factor: 6.244

6.  Status of Human Papillomavirus Infection in the Ethnic Population in Yunnan Province, China.

Authors:  Zulqarnain Baloch; Lei Yue; Tao Yuan; Yue Feng; Wenlin Tai; Yanqing Liu; Binghui Wang; Xiao Li; Li Liu; A-Mei Zhang; Xiaomei Wu; Xueshan Xia
Journal:  Biomed Res Int       Date:  2015-12-27       Impact factor: 3.411

7.  Characterization of the high-risk human papillomavirus infection in Jining, China.

Authors:  Yinfeng Jia; Huan Guo; Feifei Liu; Guangqi Zhou; Haixin Dong; Ling Bi; Jialin Jia; Hui Sun
Journal:  Braz J Infect Dis       Date:  2013-03-01       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.